Recent studies have revealed that KPNs including KPNA2 are overexpressed in various kinds of tumors such as breast cancer, cervical cancer, non-small cell lung cancer, prostate cancer, and primary cutaneous melanoma, and that expression levels in these tumors are closely associated with prognosis [13]–[18]. This evidence concerns the gene KPNA2 and cervical cancer.